SCHEDULE 13G 0001768640 XXXXXXXX LIVE Class A Common Stock, $0.00001 par value per share 05/23/2025 0001673743 Hinge Health, Inc. 433313103 455 Market Street 7th Floor San Francisco CA 94105 Rule 13d-1(d) Bessemer Venture Partners X L.P. b E9 2119271 0 2119271 0 2119271 N 7.2 PN Represents shares of Class A Common Stock of the Issuer underlying shares of Class B Common Stock beneficially owned by the Reporting Person, which shares of Class B Common Stock are convertible, at the option of the holder, into shares of Class A Common Stock on a 1-for-1 basis. The percentage of shares beneficially owned set forth in row 11 above is based on a total of 27,223,448 shares of Class A Common Stock as of July 31, 2025 as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 11, 2025. Bessemer Venture Partners X Institutional L.P. b E9 1989436 0 1989436 0 1989436 N 6.8 PN Represents shares of Class A Common Stock of the Issuer underlying shares of Class B Common Stock beneficially owned by the Reporting Person, which shares of Class B Common Stock are convertible, at the option of the holder, into shares of Class A Common Stock on a 1-for-1 basis. The percentage of shares beneficially owned set forth in row 11 above is based on a total of 27,223,448 shares of Class A Common Stock as of July 31, 2025 as reported in the Issuer's Quartlery Report on Form 10-Q filed with the Securities and Exchange Commission on August 11, 2025. Deer X & Co. L.P. b E9 4108707 0 4108707 0 4108707 N 13.1 PN Represents shares of Class A Common Stock of the Issuer underlying shares of Class B Common Stock beneficially owned by the Reporting Person, which shares of Class B Common Stock are convertible, at the option of the holder, into shares of Class A Common Stock on a 1-for-1 basis. The percentage of shares beneficially owned set forth in row 11 above is based on a total of 27,223,448 shares of Class A Common Stock as of July 31, 2025 as reported in the Issuer's Quartlery Report on Form 10-Q filed with the Securities and Exchange Commission on August 11, 2025. Deer X & Co. Ltd. b E9 4108707 0 4108707 0 4108707 N 13.1 CO Represents shares of Class A Common Stock of the Issuer underlying shares of Class B Common Stock beneficially owned by the Reporting Person, which shares of Class B Common Stock are convertible, at the option of the holder, into shares of Class A Common Stock on a 1-for-1 basis. The percentage of shares beneficially owned set forth in row 11 above is based on a total of 27,223,448 shares of Class A Common Stock as of July 31, 2025 as reported in the Issuer's Quartlery Report on Form 10-Q filed with the Securities and Exchange Commission on August 11, 2025. Hinge Health, Inc. 455 Market Street, 7th Floor, San Francisco, CA 94105 This statement is being filed by the following persons with respect to certain shares of Class B Common Stock (the "Shares" or the "Common Stock") of the Issuer. Bessemer Venture Partners X L.P. ("BVP X"), Bessemer Venture Partners X Institutional L.P. ("BVP X Inst" and together with BVP X, the "Funds") directly own shares of Common Stock. Deer X Ltd, Deer X LP, BVP X and BVP X Inst are sometimes individually referred to herein as a "Reporting Person" and collectively as the "Reporting Persons." The address of the principal business office of the Reporting Persons is: c/o Bessemer Venture Partners 1865 Palmer Avenue; Suite 104 Larchmont, NY 10583 Cayman Islands Y Deer X Ltd-4,108,707 shares DeerX LP - 4,108,707 shares BVP X - 2,119,271 shares BVP X Inst - 1,989,436 shares Deer X Ltd- 13.1% DeerX LP - 13.1% BVP X - 7.2% BVP X Inst - 6.8% Represents shares of Class A Common Stock of the Issuer underlying shares of Class B Common Stock of the Issuer beneficially owned by the Reporting Persons, which shares of Class B Common Stock are convertible, at the option of the holder, into shares of Class A Common Stock on a 1-for-1 basis. The percentage of shares beneficially owned is based on a total of 27,223,448 shares of Class A Common Stock outstanding as of July 31, 2025, as reported in the Issuer's Quartelry Report on Form 10-Q filed with the Securities and Exchange Commission on August 11, 2025. Deer X Ltd-4,108,707 shares DeerX LP - 4,108,707 shares BVP X - 2,119,271 shares BVP X Inst - 1,989,436 shares Deer X Ltd- 0 shares DeerX LP - 0 shares BVP X - 0 shares BVP X Inst - 0 shares Deer X Ltd-4,108,707 shares DeerX LP - 4,108,707 shares BVP X - 2,119,271 shares BVP X Inst - 1,989,436 shares Deer X Ltd- 0 shares DeerX LP - 0 shares BVP X - 0 shares BVP X Inst - 0 shares Y N As the general partner of Deer X LP, which in turn is the general partner of the Funds, Deer X Ltd may be deemed to beneficially own all 4,108,707 Shares held directly by the Funds and have the power to direct the dividends from or the proceeds of the sale of such Shares. Y Y Y Y Bessemer Venture Partners X L.P. /s/ Scott Ring 08/14/2025 Bessemer Venture Partners X Institutional L.P. /s/ Scott Ring 08/14/2025 Deer X & Co. L.P. /s/ Scott Ring 08/14/2025 Deer X & Co. Ltd. /s/ Scott Ring 08/14/2025